Introduction
Bladder cancer is the sixth most common cancer worldwide with an estimated annual incidence of nearly 3 000 in Australia [1, 2] . Radical cystectomy (RC) remains a primary treatment option in the management of muscle-invasive bladder cancer and high-risk superficial bladder cancer [3] . However, it is among the highest risk urological procedure, associated with a morbidity in excess of 50% and perioperative mortality of up to 8% [4] [5] [6] .
The relationship between improved outcomes for various high-risk surgical procedures undertaken in high-volume hospitals (HVH) is well established [7] . For major urological surgery, there is a growing body of evidence that RC should be undertaken in HVH to achieve best possible perioperative and long-term oncological outcomes [4] .
A recent Australian study focusing on oncological outcomes of RC found improved 5-year disease-specific survival for HVH [8] . There is limited data reporting perioperative outcomes of RC in Australia with previous studies from single-institution case series [9] or of a particular subgroup [10] . The objective of our study was to evaluate the association between hospital caseload and perioperative outcomes of RC using population data from Victoria, Australia.
Patients and Methods
Patients undergoing RC for urothelial malignancy in the state of Victoria, Australia between July 2003 and June 2014 were identified using the Victorian Admitted Episodes Dataset (VAED). The VAED collects data on all inpatient public hospital admissions in Victoria including demographics, diagnoses, and procedures. The VAED was queried using the Medicare Benefits Schedule procedure item number (37014 for RC) and International Classification of Disease, 10th revision procedure code (C67 for malignant neoplasm of bladder).
Patient characteristics included age (<75 or ≥75 years), gender, and Charlson Comorbidity Index (CCI) ≤2 or >2. The diversion type was identified from the VAED. Hospitals were divided into tertiles according to their caseload per year; defined as low-volume hospitals (LVH, <4 RCs/year), medium-volume hospitals (MVH, 4-10 RCs/year), and HVH (>10 RCs/year).
Perioperative outcomes analysed included: in-hospital mortality (IHM), length of stay (LOS), intensive care unit (ICU) admission, and requirement for blood transfusion. A prolonged LOS was defined as ≥14 days, whilst a prolonged ICU admission was defined as ≥24 h.
All statistical analyses were performed using STATA v12.0 (StataCorp LP, TX, USA). Analysis of differences between hospital-volume groups were performed using the chi-squared test or Kruskal-Wallis test. Clinical variables for prediction of perioperative outcomes were entered into univariate analyses. These included age, gender, CCI, urinary diversion type, and hospital-volume group. Predictors were then entered into a backward stepwise multivariable logistic regression model.
Statistical significance was defined as P < 0.05. This study was approved by the institution ethics committee.
Results
During the 11-year study period, 803 patients underwent RC for bladder cancer ( Table 1 ). The mean age was 66 years (22% were aged ≥75 years), with a predominantly male population (75%). In all, 18 hospitals performed RC with a caseload ranging from one to 121 procedures over the 11-year period, with 12 of the hospitals located in the metropolitan area of Melbourne. Ten hospitals were classified as LVH, six as MVH, and two as HVH. There was no significant difference between the hospital-volume groups for age, gender or comorbidities. Neobladder diversion was more commonly used in HVH (11%, 3% at LVH).
Overall, there was a 2.2% rate of IHM with a prolonged LOS rate of 45% (Table 2) . A prolonged ICU admission occurred in 31% of the patients and a blood transfusion was required in 56%. The IHM rate was 3.7%, 2.5% and 0.9% respectively for the LVH, MVH and HVH groups (P = 0.19). There was a significant difference amongst the groups for prolonged LOS and prolonged ICU admission. Whilst LVH were found to have a significantly decreased prevalence of prolonged LOS (32% vs 49% and 44%, P = 0.002) but a significantly increased prevalence of prolonged ICU admission (63% vs 30% and 13%, P < 0.001). The rates of blood transfusion were similar (50-60%, P = 0.06).
Univariate and multivariable logistic regression analyses of the volume-outcome relationship are shown in Tables 3 and  4 . Compared to HVH, LVH were significantly associated with increased IHM (odds ratio [OR] 5.74, P = 0.04) and a prolonged ICU admission (OR 11.58, P < 0.001). There was a lower rate of prolonged LOS in the LVH group (OR 0.60, P = 0.01). No significant relationship was found for LVH and blood transfusion. Table 1 Baseline characteristics overall and by hospital volume.
Number of patients (%) 803 (100) 136 (17) 438 (55) 
Discussion
The findings of the present study show that the rates of perioperative outcomes for RC achieved in Victoria are comparable to published international results. Specifically, our results highlight an IHM rate of 2.2%, which is similar to recent population studies and even case series from single high-volume institutions (2.3-3.2%) [4, [11] [12] [13] . Similarly, a blood transfusion rate of 56% is consistent with rates of 48-62% identified in other studies [14, 15] .
Our results further add to the evidence regarding the volume-outcome relationship for RC. The rate of IHM ranged from 3.7% in the LVH group to 0.9% in the HVH group. Furthermore, a significantly higher risk of IHM was found for the LVH group after multivariable analysis (OR 5.74, P = 0.04). These findings are equivalent with contemporary literature. Goossens-Laan et al. [16] published a meta-analysis including seven studies and found improved IHM for HVH (pooled OR 0.55, P < 0.01). After analysis of 35 000 RCs in the USA National Cancer Database, Nielsen et al. [4] reported a significantly increased risk (OR 1.5) of 30-day mortality for LVH (<10 RCs/year in their cohort). Improved 90-day mortality rates for HVH (≥10 RCs/year) have also been reported in Sweden (5.4% vs 8.4%, P = 0.35) [17] . Patel et al. [8] recently reported data from New South Wales, another Australian region. Whilst not statistically significant, a lower risk of 30-day (1.8% vs 4.3%) and 90-day (3.6% vs 6.4%) mortality was reported for HVH compared to LVH. It appears that RC caseload is more decentralised in New South Wales compared to Victoria. The volume threshold for HVH was defined as >6 RCs/year. However, even with this lower threshold, only 10% of their cohort underwent surgery in HVH compared to nearly 30% in our cohort. Additionally, whilst a multivariable analysis was undertaken for longer-term outcomes, there was no adjustment for other variables when analysing for short-term mortality.
In the present study, we found a significant relationship between LVH and prolonged ICU admission (OR 11.58, P < 0.001), a finding that has also been reported by Gorin et al. [18] in the USA state of Maryland. For LOS and blood transfusion, there were varied results for MVH and LVH when compared to HVH. There was a significantly lower rate of prolonged LOS in the LVH group, whilst a higher rate was found for MVH. The MVH group had a higher blood transfusion requirement (OR 1.38, P = 0.03) than the LVH group (OR 1.18, P = 0.43 on univariate analysis). For LOS, most studies have reported an inverse relationship with [18, 19] . Decreased rates of blood transfusion have also been reported for HVH [19, 20] . Our results for LOS by hospital volume were discordant from the expected findings. This may be a result of the limitations of our dataset. Upon further examination, a higher proportion of patients in HVH were discharged home (83% vs 71% in LVH) instead of being transferred to a rehabilitation unit where further LOS data were not available. Additionally, this could reflect that due to the limited exposure of many Victorian hospitals to RC, management of patients is highly heterogeneous across many aspects of the perioperative course, including discharge. Mir et al. [21] have recently emphasised the importance of implementing Enhanced Recovery After Surgery (ERAS) pathways for RC in Australia, which have been shown to improve perioperative outcomes internationally [22] . The increased IHM observed for neobladder urinary diversion was also not expected, as these patients were younger and had less comorbidity. This paradox has also been reported previously [23, 24] . With only 67 neobladders being performed over the 11-year period, larger studies are required before coming to any conclusions in the Australian setting.
It is likely that the reason for the hospital volume-outcome relationship is multi-factorial. First, HVH are more likely to have high-volume surgeons. Birkmeyer et al. [25] demonstrated that surgeon volume contributed to~40% of the effect of hospital volume on operative mortality. Unfortunately, no data are currently available for surgeon volume and RC in Victoria. Second, HVH may have improved perioperative processes of care. A higher staff ratio of nurses and urology trainees have been shown to have a lower rate of IHM [26] and decreased LOS [27] .
Our results show that the centralisation of RC in Australia should be further examined. In the UK, Hounsome et al. [28] have shown the improvement in RC outcomes achieved after the introduction of volume guidelines. A minimum caseload of 5 RCs/year/surgeon and 50 major urological procedures/ year/hospital was recommended. Over a 12-year period, there was a decrease in 30-day mortality from 5.2% to 2.1% and a decrease in 90-day mortality from 10.3% to 5.1%. Analysing the USA Nationwide Inpatient Sample, Ravi et al. [19] concluded that there would be one less IHM for every 50 patients diverted from LVH to HVH. In Australia, the role of centralisation of high-risk surgical procedures has been considered and recently guidelines dictating a minimum caseload for oesophagectomies and pancreatectomies have been released [29, 30] . The introduction of an Australian nephrectomy registry [31] will likely be followed by other urology procedures, such as RC, and these data will assist to direct any quality improvements required. Analysis of practice led by large audits has been shown in other Australian specialties [32, 33] . For RC, Jerlstr€ om et al. [34] have established a prospective RC database in Sweden with preliminary analysis identifying increased operating time and older patients as risk factors for higher complication rates. Indeed, the introduction of national RC databases may be further able to identify factors that may improve RC outcomes locally. Moreover, specialised training through fellowship has also been correlated with improved outcomes for major urological procedures [35] and, in Australia, has been shown to positively affect trainees as primary operators under their supervision [36] . However, the widespread introduction of fellows need to be carefully examined, with Australian surgical trainees reporting decreased case exposure and clinical experience if a fellow is attached to a unit [37] .
There are several limitations to the present study. Firstly, it was not possible to identify individual surgeon volume from the VAED. Histopathological and clinical staging is not included in the VAED and data linkage to the Victorian Cancer Registry for the whole study period was not possible. Whilst an increased risk of 30-day mortality for patients with advanced stage bladder cancer has been observed by Nielsen et al. [4] , there was no increase in rates of ICU admission, blood transfusion and complications found in other studies [38] . There is also no differentiation in the VAED between blood transfusions received in the intra-or post-operative period nor the number of units required. This is a limitation observed in other population studies [19, 20] . Further, quantitative data pertaining to the volume of transfusions administered during admission were not available for analysis. Additionally, we were unable to record post-hospital events including readmission, complications and longer-term mortality from the dataset. This issue was also encountered by Patel et al. [8] who used an advanced probabilistic linkage technique. Finally, there is no accepted definition of the minimum caseload required to be classified as high volume. Our hospital-volume classifications were based on the different caseloads performed in the specific Victorian population. In other studies as shown in Table 5 [4, 17, 18, 26, 27, [39] [40] [41] [42] [43] , there is marked variation in the minimum volume threshold for HVH (ranging from 2.75 to 63.5 per year). Analysis of different thresholds has not identified a particular hospital volume associated with a greater volume-outcome relationship [16] . These variations make it difficult to compare and quantify hospital volume effects between populations, and create a challenge when formulating guidelines for recommending minimum caseloads.
Our study shows that comparable perioperative outcomes to international cohorts are being achieved in Victoria. RC is relatively decentralised, with more than half of the institutions in Victoria undertaking an average of less than four cases per year. Our results add further population-study evidence to the hospital volume-outcome relationship in RC. A significant association was found between LVH and both IHM and prolonged ICU admission. It appears that this subgroup of patients would benefit from transfer of care to a HVH. Centralisation of RC in Australia should be further considered.
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